http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13586913

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 2176
issn 1065-6995
1095-8355
issueIdentifier 10
pageRange 2170-2176
publicationName Cell Biology International
startingPage 2170
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c3c09c9d6740afaea9a5669c8eb7a3c1
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c2cd38b6617434252e5c4691f3fef8d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_84d287784b7120f0dbc958ac4be701e8
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ac2b2335d50740a515cbe8ec47f63f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3970926b99ae3be12dc60fed684515c2
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Gao M, Guo L, Wang H, Huang J, Han F, Xiang S, Wang J. Orphan nuclear receptor RORγ confers doxorubicin resistance in prostate cancer. Cell Biology International. 2020 Jul 07;44(10):2170–6. doi: 10.1002/cbin.11411.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f183469a85706ced10934b2da43e09e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c449bbf0b3df72590d7dbb23803b570
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21d50b1193874f673fb43cd47cdbb99b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d292294ce4f445b727b5193527a37bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f408eb8e8ed2900eb69b75dc09bd2e03
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f09e129bda6dee0105468656a3c72e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e88a966336c2db85e9ef0a598f9ff13
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5328-2908
date 2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/cbin.11411
https://pubmed.ncbi.nlm.nih.gov/32584473
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2362
https://portal.issn.org/resource/ISSN/1065-6995
https://portal.issn.org/resource/ISSN/1095-8355
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Orphan nuclear receptor RORγ confers doxorubicin resistance in prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0534742
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015972
http://id.nlm.nih.gov/mesh/D064129Q000235
http://id.nlm.nih.gov/mesh/D019008
http://id.nlm.nih.gov/mesh/D057132Q000502
http://id.nlm.nih.gov/mesh/D004317Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D064129Q000188
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130248006
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71285927
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51035449

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6097

Total number of triples: 52.